University of Pittsburgh Medical Center (UPMC)
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, Pennsylvania, United States10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Platform of Randomized Adaptive Clinical Trials in Critical Illness | Respiration Disorders, respiratory failure, respiratory system disorder | Recruiting | Not applicable | 2026-10-06 | NCT05440851 | |
| A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 1 | 2026-10-05 | NCT07187973 | |
| Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene | X-Linked Retinitis Pigmentosa | Active, not recruiting | Phase 3 | 2026-09-25 | NCT04794101 | |
| Periprosthetic Joint Infection Bubble Study | Periprosthetic Joint Infection (PJI) | Recruiting | Phase 2 | 2026-09-23 | NCT07599865 | |
| An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder | Recruiting | Not applicable | 2026-09-17 | NCT06035120 | |
| A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, disorder of glycogen metabolism, glycogen storage disease II, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, nervous system disorder, neuromuscular disease | Recruiting | Phase 1 / Phase 2 | 2026-07-20 | NCT07282847 | |
| INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2026-05-11 | NCT07543367 | |
| Understanding the Long-term Impact of COVID on Children and Families | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2025-12-31 | NCT05172011 | |
| Posterior Cervical Fixation Study | Bone Diseases, Developmental, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocervical Injuries, Klippel-Feil syndrome, Musculoskeletal Abnormalities, Radiculopathy, Cervical, Thoracic Injuries, bone disorder, dysostosis, injury, intervertebral disk degenerative disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, neuromuscular disease, peripheral nervous system disorder, radiculopathy, vertebral column disorder | Enrolling by invitation | Not stated | 2025-12-22 | NCT04770571 | |
| Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficiencies | Active, not recruiting | Phase 3 | 2025-10-14 | NCT04988386 |